Hosted on MSN
Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth
The company raised 2025 total revenue guidance to $310 million–$320 million. Stokes explained that “our normalized revenue growth range in 2025 would be approximately 21% to 26%” when excluding ...
In today’s competitive semiconductor market, revenue growth is often associated with design innovation, process advancements, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results